Trials / Sponsors / H Scott Boswell
H Scott Boswell
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib AML, AML, Adult | Phase 1 / Phase 2 | 2019-09-20 |